BioCentury | Apr 13, 2021
Politics, Policy & Law

FDA eases abortion drug access, responding to calls from women, docs and Democrats

...“The biotech industry should worry about politics being put ahead of public health,” Pendergast stated. Steve Usdin U.S. Food and Drug Administration (FDA) Mifepristone Mary...
BioCentury | Apr 13, 2021
Product Development

FDA’s ‘pause’ could lead to narrowed indication for J&J COVID-19 vaccine

...and has “made the decision to proactively delay the rollout of our vaccine in Europe.” Steve Usdin U.S. Food and Drug Administration (FDA) Johnson...
BioCentury | Apr 13, 2021
Regulation

Competence & continuity at CDER; plus BIO 3.0, AACR and 2Q preview: a BioCentury podcast

...at conferences@biocentury.com. Jeff Cranmer Biotechnology Innovation Organization Shanghai Genechem Co. Ltd. U.S. Food and Drug Administration (FDA) AACR Michelle...
BioCentury | Apr 12, 2021
Politics, Policy & Law

Cavazzoni brings competence, continuity as CDER director

...pandemic will be retained and how the center should adopt lessons learned from the experience. Steve Usdin U.S. Food and Drug Administration (FDA) Pfizer...
BioCentury | Apr 7, 2021
Product Development

FDA could delay decision on AstraZeneca COVID-19 vaccine

...and Assistant Editor Sandi Wong contributed to this story. Steve Usdin AstraZeneca plc Pfizer Inc. BioNTech SE Moderna Inc. Johnson & Johnson U.S. Food and Drug Administration (FDA) European...
BioCentury | Mar 30, 2021
Deals

Abernethy and the obvious at FDA; plus CEPI and EpimAb: a BioCentury podcast

...surveys. For more information, please contact Eric Pierce and Josh Berlin at conferences@biocentury.com. Jeff Cranmer EpimAb Biotherapeutics Inc. U.S. Food and Drug Administration (FDA) Coalition...
BioCentury | Mar 26, 2021
Politics, Policy & Law

Abernethy tackled ‘the blooming obvious’ at FDA by improving tech and data

...future to keep moving forward.” Steve Usdin Flatiron Health Inc. Roche U.S. Food and Drug Administration (FDA) Friends...
BioCentury | Mar 20, 2021
Politics, Policy & Law

Twilight of HHS sunset rule

...of the Trump administration as evidence that he worked to “drain the swamp” in Washington. Steve Usdin U.S. Food and Drug Administration (FDA) sunset...
BioCentury | Mar 20, 2021
Politics, Policy & Law

Becerra’s confirmation, O’Connell nomination spotlight FDA commissioner choice

...senior counselor to HHS Secretary Sylvia Burwell. Steve Usdin U.S. Food and Drug Administration (FDA) U.S...
BioCentury | Mar 17, 2021
Product Development

FDA gets explicit about asymptomatic screening tests

...testing, which could enable more people to benefit from serial testing regimens. Karen Tkach Tuzman Cue Health Inc. U.S. Food and Drug Administration (FDA) cov19dx covid19 covid-19 asymptomatic screening...
Items per page:
1 - 10 of 1281
BioCentury | Apr 13, 2021
Politics, Policy & Law

FDA eases abortion drug access, responding to calls from women, docs and Democrats

...“The biotech industry should worry about politics being put ahead of public health,” Pendergast stated. Steve Usdin U.S. Food and Drug Administration (FDA) Mifepristone Mary...
BioCentury | Apr 13, 2021
Product Development

FDA’s ‘pause’ could lead to narrowed indication for J&J COVID-19 vaccine

...and has “made the decision to proactively delay the rollout of our vaccine in Europe.” Steve Usdin U.S. Food and Drug Administration (FDA) Johnson...
BioCentury | Apr 13, 2021
Regulation

Competence & continuity at CDER; plus BIO 3.0, AACR and 2Q preview: a BioCentury podcast

...at conferences@biocentury.com. Jeff Cranmer Biotechnology Innovation Organization Shanghai Genechem Co. Ltd. U.S. Food and Drug Administration (FDA) AACR Michelle...
BioCentury | Apr 12, 2021
Politics, Policy & Law

Cavazzoni brings competence, continuity as CDER director

...pandemic will be retained and how the center should adopt lessons learned from the experience. Steve Usdin U.S. Food and Drug Administration (FDA) Pfizer...
BioCentury | Apr 7, 2021
Product Development

FDA could delay decision on AstraZeneca COVID-19 vaccine

...and Assistant Editor Sandi Wong contributed to this story. Steve Usdin AstraZeneca plc Pfizer Inc. BioNTech SE Moderna Inc. Johnson & Johnson U.S. Food and Drug Administration (FDA) European...
BioCentury | Mar 30, 2021
Deals

Abernethy and the obvious at FDA; plus CEPI and EpimAb: a BioCentury podcast

...surveys. For more information, please contact Eric Pierce and Josh Berlin at conferences@biocentury.com. Jeff Cranmer EpimAb Biotherapeutics Inc. U.S. Food and Drug Administration (FDA) Coalition...
BioCentury | Mar 26, 2021
Politics, Policy & Law

Abernethy tackled ‘the blooming obvious’ at FDA by improving tech and data

...future to keep moving forward.” Steve Usdin Flatiron Health Inc. Roche U.S. Food and Drug Administration (FDA) Friends...
BioCentury | Mar 20, 2021
Politics, Policy & Law

Twilight of HHS sunset rule

...of the Trump administration as evidence that he worked to “drain the swamp” in Washington. Steve Usdin U.S. Food and Drug Administration (FDA) sunset...
BioCentury | Mar 20, 2021
Politics, Policy & Law

Becerra’s confirmation, O’Connell nomination spotlight FDA commissioner choice

...senior counselor to HHS Secretary Sylvia Burwell. Steve Usdin U.S. Food and Drug Administration (FDA) U.S...
BioCentury | Mar 17, 2021
Product Development

FDA gets explicit about asymptomatic screening tests

...testing, which could enable more people to benefit from serial testing regimens. Karen Tkach Tuzman Cue Health Inc. U.S. Food and Drug Administration (FDA) cov19dx covid19 covid-19 asymptomatic screening...
Items per page:
1 - 10 of 1281